A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil

Promoting, improving and accelerating the drug development and approval processes

(2010) A.I. Graul   DRUG NEWS & PERSPECTIVES

Development of 2D chiral chromatography with accelerator mass spectrometry for quantification of 14C-labeled R- and S-verapamil in plasma

(2010) M Simpson et al.   Bioanalysis

A pharmacokinetic evaluation of five H1antagonists after an oral and intravenous microdose to human subjects

(2009) Ajay Madan et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy

(2009) Paola Iannetti et al.   EPILEPSY RESEARCH

A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood-Brain Barrier with (R)-11C-Verapamil and PET

(2009) C. C. Wagner et al.   JOURNAL OF NUCLEAR MEDICINE

New ultrasensitive detection technologies and techniques for use in microdosing studies

(2009) Graham Lappin et al.   Bioanalysis

The utility of microdosing over the past 5 years

(2008) Graham Lappin et al.   Expert Opinion on Drug Metabolism & Toxicology

Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics

(2008) Graham Lappin et al.   Expert Opinion on Drug Metabolism & Toxicology